Rohto-Mentholatum (Vietnam) Co., Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Apr 14, 2026
  • Last warning letter 2026
Inspections 5 2 OAI
Recalls 8 0 Class I (0%)
Warning letters 1 Latest Oct 14, 2026
510(k) clearances 0 None on file

Rohto-Mentholatum (Vietnam) Co., Ltd. has 8 FDA recalls, 5 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Rohto-Mentholatum (Vietnam) Co., Ltd., the most recent on Oct 14, 2026.

What these totals cover: FDA records filed under the name "Rohto-Mentholatum (Vietnam) Co., Ltd." and its spelling variant "Rohto-Mentholatum (Vietnam) Co".

Latest recall
D-0719-2026 · Class II · Jul 14, 2026
Latest inspection
Apr 14, 2026 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls8Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections5Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Rohto-Mentholatum (Vietnam) Co., Ltd.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Rohto-Mentholatum (Vietnam) Co., Ltd.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (1 OAI), 1 warning letter, 8 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202611180
202500000
202400000
202300000
202200000
202100000
202000000
201910000
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Rohto-Mentholatum (Vietnam) Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Rohto-Mentholatum (Vietnam) Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Rohto-Mentholatum (Vietnam) Co., Ltd. FDA Warning Letters

1 warning letter on Oct 14, 2026.

IssuedSubjectIssuing officeClose-out letter
Oct 14, 2026 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

8 recall records on Jul 14, 2026.

NumberClassProductDate
D-0719-2026Class IIRohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL…Jul 14, 2026
D-0722-2026Class IIRohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%)…Jul 14, 2026
D-0718-2026Class IIRohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol…Jul 14, 2026
D-0717-2026Class IIRohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%)…Jul 14, 2026
D-0716-2026Class IIRohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%)…Jul 14, 2026
D-0715-2026Class IIRohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate…Jul 14, 2026
D-0721-2026Class IIRohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, TWIN PACK 0.34 FL…Jul 14, 2026
D-0720-2026Class IIRohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10…Jul 14, 2026

Recent FDA inspections

5 inspections from May 15, 2012 to Apr 14, 2026.

DateSiteProductClassificationFEI
Apr 14, 2026Ho Chi Minh, VietnamDrugsOfficial Action Indicated (OAI)3008808745
Nov 1, 2019Ho Chi Minh, VietnamDrugsVoluntary Action Indicated (VAI)3008808745
Mar 16, 2018Ho Chi Minh, VietnamDrugsVoluntary Action Indicated (VAI)3008808745
Apr 14, 2015Ho Chi Minh, VietnamDrugsVoluntary Action Indicated (VAI)3008808745
May 15, 2012Ho Chi Minh, VietnamDrugsOfficial Action Indicated (OAI)3008808745
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Rohto-Mentholatum (Vietnam) Co., Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Oct 14, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008808745Ho Chi Minh, Vietnam5Apr 14, 2026

Rohto-Mentholatum (Vietnam) Co., Ltd. and the FDA: common questions

Has Rohto-Mentholatum (Vietnam) Co., Ltd. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Rohto-Mentholatum (Vietnam) Co., Ltd.. The most recent is dated Oct 14, 2026.

Has Rohto-Mentholatum (Vietnam) Co., Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Rohto-Mentholatum (Vietnam) Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Rohto-Mentholatum (Vietnam) Co., Ltd.?

The most recent FDA inspection on file ended Apr 14, 2026 at Ho Chi Minh, Vietnam and was classified OAI. FDA has 5 inspections of Rohto-Mentholatum (Vietnam) Co., Ltd. on file, 2 of them classified OAI (official action indicated).

Has Rohto-Mentholatum (Vietnam) Co., Ltd. had an FDA recall?

Yes. Rohto-Mentholatum (Vietnam) Co., Ltd. has 8 FDA recalls on record. The most recent started Jul 14, 2026.

Need more than this page shows? Ask about Rohto-Mentholatum (Vietnam) Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.